Cambridge, MA, United States of America

Tcr2 Therapeutics Inc.


USPTO Granted Patents = 9


Trademarks = 4

Forward Citations = 30

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Robert Hofmeister (9 out of 15 patents)

silverMedal Patrick A Baeuerle (9 out of 35 patents)

bronzeMedal Gregory Sieczkiewicz (8 out of 11 patents)

4 Robert B Dubridge (1 out of 47 patents)

5 Holger Wesche (1 out of 26 patents)

6 Richard J Austin (1 out of 23 patents)

7 Bryan D Lemon (1 out of 23 patents)

8 Patrick Baeuerle (0 patent)


9 patents:

TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell receptor fusion construct (TRuC-T cells) therapies for cancer patients. The company's proprietary TRuC-T cells have the potential to overcome key limitations of current T cell therapies and offer a novel approach to treating solid tumors and hematologic malignancies. TCR2 Therapeutics is committed to advancing the field of cell therapy and improving outcomes for cancer patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

9 Patents

#224 in Cambridge, MA

#1,869 in Massachusetts

#31,684 in US

...
Cambridge, MA, United States of America
Forward Citations = 30

7 inventors:

Please report any incorrect information to support@idiyas.com
Loading…